Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Gains from Sales and Divestitures (2019 - 2025)

Eton Pharmaceuticals' Gains from Sales and Divestitures history spans 6 years, with the latest figure at $159150.0 for Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures rose 76.05% to $159150.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $159150.0, a 76.05% increase, with the full-year FY2025 number at $159150.0, up 76.05% from a year prior.
  • Gains from Sales and Divestitures hit $159150.0 in Q4 2025 for Eton Pharmaceuticals, up from $84204.0 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for ETON hit a ceiling of $159150.0 in Q4 2025 and a floor of $889.0 in Q2 2025.
  • Historically, Gains from Sales and Divestitures has averaged $76930.8 across 4 years, with a median of $90402.0 in 2024.
  • The widest YoY moves for Gains from Sales and Divestitures: up 76.05% in 2025, down 6.86% in 2025.
  • Tracing ETON's Gains from Sales and Divestitures over 4 years: stood at $7595.0 in 2021, then skyrocketed by 1103.45% to $91402.0 in 2023, then dropped by 1.09% to $90402.0 in 2024, then surged by 76.05% to $159150.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for ETON at $159150.0 in Q4 2025, $84204.0 in Q3 2025, and $889.0 in Q2 2025.